Tema Heart & Health ETF (NASDAQ:HRTS) Trading Up 1% – Here’s Why

Tema Heart & Health ETF (NASDAQ:HRTS)’s stock price was up 1% during trading on Monday . The stock traded as high as $36.63 and last traded at $36.55. Approximately 12,327 shares changed hands during mid-day trading, an increase of 92% from the average session volume of 6,421 shares. The stock had previously closed at $36.19.

Tema Heart & Health ETF Stock Performance

The business’s 50-day moving average price is $34.10 and its 200 day moving average price is $34.70. The stock has a market capitalization of $54.00 million, a PE ratio of 22.06 and a beta of 0.68.

Hedge Funds Weigh In On Tema Heart & Health ETF

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. CoreCap Advisors LLC raised its holdings in shares of Tema Heart & Health ETF by 17.2% in the 4th quarter. CoreCap Advisors LLC now owns 60,679 shares of the company’s stock valued at $2,141,000 after acquiring an additional 8,903 shares in the last quarter. Jane Street Group LLC grew its holdings in shares of Tema Heart & Health ETF by 9.4% during the second quarter. Jane Street Group LLC now owns 37,164 shares of the company’s stock worth $1,062,000 after purchasing an additional 3,202 shares in the last quarter. Stifel Financial Corp increased its position in shares of Tema Heart & Health ETF by 19.8% in the fourth quarter. Stifel Financial Corp now owns 33,647 shares of the company’s stock worth $1,187,000 after purchasing an additional 5,571 shares during the last quarter. Royal Bank of Canada increased its position in shares of Tema Heart & Health ETF by 8.8% in the first quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock worth $710,000 after purchasing an additional 1,703 shares during the last quarter. Finally, Brookstone Capital Management purchased a new stake in Tema Heart & Health ETF in the fourth quarter valued at approximately $364,000.

Tema Heart & Health ETF Company Profile

The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.